Bacterial Meningitis (ASM)

Bacterial meningitis continues to be an important cause of mortality and morbidity throughout the world. Here is the latest research.

December 11, 2020

Post colonoscopic Listeria monocytogenes meningitis in a patient with multiple myeloma during daratumumab-based therapy

[Rinshō ketsueki] The Japanese journal of clinical hematology
Fuka HorikitaTakahiro Nagashima
January 5, 2021

Intracranial bruits in meningitis

Internal and Emergency Medicine
Kenta Sugiura, Takateru Ihara
December 29, 2020
Case Report

Utility of multiplex PCR syndromic panel for respiratory infections in the diagnosis of acute bacterial meningitis

Enfermedades infecciosas y microbiología clínica
María Ángeles Asencio EgeaMaría Huertas Vaquero
January 7, 2021
Open Access

Colonization of dermal arterioles by Neisseria meningitidis provides a safe haven from neutrophils

BioRxiv : the Preprint Server for Biology
V. ManriquezG. Dumenil
December 29, 2020
Open Access

CSF Levels of Elongation Factor Tu Is Associated With Increased Mortality in Malawian Adults With Streptococcus pneumoniae Meningitis

Frontiers in Cellular and Infection Microbiology
Emma C WallJeremy S Brown
January 13, 2021

Cerebral venous thrombosis in pneumococcal meningitis: An autopsy study

Clinical Neuropathology
Shahrzad S DeliranDiederik van de Beek
January 1, 2021

Predictors of mortality in invasive pneumococcal disease: a meta-analysis

Expert Review of Anti-infective Therapy
Tuna DemirdalBusra Emir
December 15, 2020
Case Report
Open Access

Bacterial Meningitis Due to Streptococcus pneumoniae in a 7-Month-Old Girl Who Received Three Doses of 13-Valent Pneumococcal Conjugate Vaccine

Journal of Nippon Medical School = Nippon Ika Daigaku Zasshi
Keishi YoshidaYasuhiko Itoh
December 15, 2020
Open Access

Incidence of Meningitis in Patients Presenting With Febrile Seizures

Amr EldardearMeshal Khaled S Aloufi
December 29, 2020
Open Access

Meningococcal disease epidemiology in Brazil (2005-2018) and impact of MenC vaccination

Altacílio Aparecido NunesEliana Nogueira Castro De Barros
December 29, 2020
Open Access

Investigation of pneumococcal virulence factors in the infection process

Nihon saikingaku zasshi. Japanese journal of bacteriology
Masaya Yamaguchi
January 6, 2021

Evaluation of FilmArray ME panel for the rapid diagnosis of meningitis-encephalitis in emergency departments

Internal and Emergency Medicine
Javier EnaFrancisco Arjona-Zaragozi
January 6, 2021
Open Access

The search for novel treatment strategies for Streptococcus pneumoniae infections

FEMS Microbiology Reviews
F CoolsP Cos
December 20, 2020

Encephalitis and Meningitis in Western Africa: A Scoping Review of Pathogens

Tropical Medicine & International Health : TM & IH
Shawheen J Rezaei, Farrah J Mateen
January 8, 2021
Case Report
Open Access

Austrian syndrome, ceftriaxone-induced agranulocytosis and COVID-19

BMJ Case Reports
James Edward McCullochJeremy Reid

Sign up to follow this feed and discover related papers.

Related Feeds

Allergy & Infectious Diseases (ASM)

Allergies result from the hyperreactivity of the immune system to some environmental substance and can be life-threatening. Infectious diseases are caused by organisms including bacteria, viruses, fungi and parasites. They can be transmitted different ways, such as person-to-person. Here is the latest research on allergy and infectious diseases.

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Anthelmintics (ASM)

Anthelmintics or antihelminthics are a group of antiparasitic drugs that expel parasitic worms (helminths) and other internal parasites from the body by either stunning or killing them and without causing significant damage to the host. Discover the latest research on anthelmintics here.

Anthrax Vaccines (ASM)

Three different types of anthrax vaccines are available; a live-attenuated, an alum-precipitated cell-free filtrate and a protein recombinant vaccine. The effectiveness between the three is uncertain, but the live-attenuated have shown to reduce the risk of anthrax with low adverse events. Here is the latest research on anthrax vaccines.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antitubercular Agents (ASM)

Antitubercular agents are pharmacologic agents for treatment of tuberculosis. Discover the latest research on antitubercular agents here.

Antivirals (ASM)

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Ascariasis (ASM)

Ascariasis is a helminthic infection of global distribution with more than 1.4 billion persons infected throughout the world. Here is the latest research.

Aspergillosis (ASM)

Aspergillosis is the name given to a wide variety of diseases caused by infection by fungi of the genus Aspergillus. Aspergillosis occurs in chronic or acute forms which are clinically very distinct. Most cases of acute aspergillosis occur in patients with severely compromised immune systems. Chronic colonization or infection can cause complications in people with underlying respiratory illnesses. Discover the latest research on aspergillosis here.

© 2021 Meta ULC. All rights reserved